Vimarsana
Biggest News Aggregation in the World

Antitumor Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Antitumor Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Antitumor Effects Today - Breaking & Trending Today

15 Health Benefits Of Drinking Pomegranate Juice - Vimarsana News

15 Health Benefits Of Drinking Pomegranate Juice

Here discover 15 pomegranate juice benefits that can add nourishing components to your daily diet according to research.

Source: femina.in
Spicing up the fight: Saffron's powerful impact on prostate cancer revealed - Vimarsana News

Spicing up the fight: Saffron's powerful impact on prostate cancer revealed

Saffron-treated prostate cancer (PCa) cells.

Can Ivermectin Treat COVID mRNA Vaccine Induced Turbo Cancers? - Vimarsana News

Can Ivermectin Treat COVID mRNA Vaccine Induced Turbo Cancers?

The Expose recently shared another review by Doctor Makis – The Anti Parasitic Drug That is Cheap, Safe & Kills Aggressive Cancers – But Has Not Been FDA Approved. which was about the nati parasitic drug Fenbendazole.

Driver of responses to checkpoint inhibitors suggests way to improve cancer therapy - Vimarsana News

Driver of responses to checkpoint inhibitors suggests way to improve cancer therapy

Expansion of a diverse subset of T-cell clones influences how patients respond to immune checkpoint inhibitors.

Curis Reports Updated Data in Two Abstracts for CA-4948 Accepted for Presentation at the European Hematology Association 2021 Virtual Congress - Vimarsana News

Curis Reports Updated Data in Two Abstracts for CA-4948 Accepted for Presentation at the European Hematology Association 2021 Virtual Congress

Share this article Share this article LEXINGTON, Mass., May 12, 2021 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that two abstracts for CA-4948, a novel, small molecule IRAK4 inhibitor, have been accepted for oral and poster presentation at the European Hematology Association 2021 Virtual Congress (EHA), which will be held virtually from June 9-17, 2021. The abstracts include updated data from a February data-cut for its ongoing open-label, single arm, Phase 1/2 study of...